Ticker Details
Vir Biotechnology, Inc.
IPO Date:	October 11, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.74B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.91 | 3.67%
Avg Daily Range (30 D):	$0.31 | 3.30%
Avg Daily Range (90 D):	$0.28 | 2.97%

Institutional Daily Volume
Avg Daily Volume:	1.1M
Avg Daily Volume (30 D):	1.52M
Avg Daily Volume (90 D):	1.75M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	76
Avg Trade Size (Sh.) (90 D):	83

Institutional Trades
Total Institutional Trades:	3,315
Avg Institutional Trade:	$2.44M
Avg Institutional Trade (30 D):	$3.64M
Avg Institutional Trade (90 D):	$2.63M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.48M
Avg Closing Trade (30 D):	$5.46M
Avg Closing Trade (90 D):	$4M
Avg Closing Volume:	196.44K

News

May 23, 2026 @ 10:13 PM Why a Biotech Fund Opened a New $6 Million Positio... Source: Jonathan Ponciano

May 14, 2026 @ 2:55 PM "Cold" Solid Tumors Become the Proving Ground for ... Source: World Street Intelligence News Commentary

Apr 12, 2026 @ 1:13 PM Vir Biotechnology (VIR) CEO Sells 73,000 Shares fo... Source: Cory Renauer

Feb 24, 2026 @ 1:31 PM Stock Market Today: S&P 500 Futures Slip As Dow, N... Source: Rishabh Mishra

Dec 7, 2025 @ 7:25 AM Is Alnylam Pharmaceuticals a Millionaire Maker? Source: Keith Speights

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.85	$-.3	$-3.16
Diluted EPS	$-.85	$-.3	$-3.16
Revenue	$-.03M	$64.07M	$68.56M
Gross Profit			$68.53M
Net Income / Loss	$-125.7M	$-42.92M	$-437.99M
Operating Income / Loss	$-132.29M	$-47.92M	$-479.33M
Cost of Revenue			$.03M
Net Cash Flow	$41.97M	$61.81M	$-77.63M
PE Ratio